Seasoned Veterans Join INC Research Board of Directors
27 May 2008
INC Research, a therapeutically-focused contract research organization (CRO) with a process for delivering reliable results, today announced that David Gill and William Hall have been elected to its Board of Directors. Both new members bring necessary expertise to help guide the company’s strategic growth plans.
David Gill, former CFO of NxStage Medical, will also serve as the chairman of INC Research's Audit Committee, which has the responsibility to ensure the integrity of financial statements and performance of internal and external audits. Gill has held various executive roles with emerging medtech and information technology companies, where during his tenure revenue and shareholder value significantly increased. Gill has been a frequent presenter at investment conferences and is well known within the healthcare industry.
Hall is co-founder and chairman of Procyon Technologies, Inc., a Chicago-based holding company. He also currently serves as an adjunct professor at the Ross School of Business Administration and as a member of the Leadership Council of the Life Sciences Institute at the University of Michigan. Previously Hall served as chairman and CEO of Falcon Building Products, a subsidiary of Eagle Industries, a privately held US$2.4 billion diversified manufacturing company founded by investor, Sam Zell.
"We are privileged to welcome such strong talent to our Board during this exciting period of growth," said James Ogle, CEO of INC Research. "David brings a tremendous amount of financial expertise and executive experience from the life sciences industry, and Bill provides a unique strategic perspective based on his background in both academic and business leadership roles. After our extensive search, with the addition of David and Bill, we feel we have the right people in place to truly take INC Research to the next level."
